Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Psychiatry Res ; 183(1): 1-20, 2010 Jul 30.
Article in English | MEDLINE | ID: mdl-20538437

ABSTRACT

The orbitofrontal cortex (OFC) is located on the basal surface of the frontal lobe and is distinguished by its unique anatomical and functional features. Clinical and postmortem studies suggest the involvement of the orbitofrontal cortex in psychiatric disorders. However, the exact parcellation of this cortical region is still a matter of debate. Therefore, the goal of this study is to provide a detailed description of the extent of borders of individual orbitofrontal cortical areas using cytoarchitectonic criteria in a large sample of human brains, which could be applied by independent neuroanatomists. To make this microscopic parcellation useful to neuroimaging studies, magnetic resonance images of postmortem brains in the coronal plane were collected prior to the preparation of coronal histological sections from the same brains. A complete series of coronal sections from 6 normal human brains and partial sections from the frontal cortex of 21 normal human brains were stained with general histological and immunohistochemical methods specific for different cell-types. These sections were examined microscopically by two independent neuroanatomists (HBMU and GR) to achieve reproducible delineations. After the borders were determined, the tissue sections were superimposed on the corresponding magnetic resonance images. Based on our cytoarchitectonical criteria, Brodmann's areas 47 and 11 were included in the human orbitofrontal cortex. Area 47 was further subdivided into three medial (located on the medial, anterior and posterior orbital gyri) and two lateral (located on the lateral orbital gyrus) subareas. In addition, we observed an anterior-posterior gradient in the cytoarchitecture of areas 11 and 47. The transverse orbital sulcus corresponds roughly to the transition between the subregions of the anterior and posterior OFC. Finally, the present delineation is contrasted with an overview of the different published nomenclatures for the OFC parcellation.


Subject(s)
Brain Mapping , Imaging, Three-Dimensional , Magnetic Resonance Imaging , Prefrontal Cortex/anatomy & histology , Adult , Aged , Aged, 80 and over , Female , Humans , Image Interpretation, Computer-Assisted/methods , Image Processing, Computer-Assisted/methods , Imaging, Three-Dimensional/methods , Magnetic Resonance Imaging/methods , Male , Middle Aged , Postmortem Changes , Young Adult
2.
Mol Ther ; 18(4): 715-24, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20179682

ABSTRACT

For many experiments in the study of the peripheral nervous system, it would be useful to genetically manipulate primary sensory neurons. We have compared vectors based on adeno-associated virus (AAV) serotypes 1, 2, 3, 4, 5, 6, and 8, and lentivirus (LV), all expressing green fluorescent protein (GFP), for efficiency of transduction of sensory neurons, expression level, cellular tropism, and persistence of transgene expression following direct injection into the dorsal root ganglia (DRG), using histological quantification and qPCR. Two weeks after injection, AAV1, AAV5, and AAV6 had transduced the most neurons. The time course of GFP expression from these three vectors was studied from 1 to 12 weeks after injection. AAV5 was the most effective serotype overall, followed by AAV1. Both these serotypes showed increasing neuronal transduction rates at later time points, with some injections of AAV5 yielding over 90% of DRG neurons GFP(+) at 12 weeks. AAV6 performed well initially, but transduction rates declined dramatically between 4 and 12 weeks. AAV1 and AAV5 both transduced large-diameter neurons, IB4(+) neurons, and CGRP(+) neurons. In conclusion, AAV5 is a highly effective gene therapy vector for primary sensory neurons following direct injection into the DRG.


Subject(s)
Dependovirus/classification , Ganglia, Spinal , Genetic Therapy , Genetic Vectors , Animals , Dependovirus/genetics , Female , Plasmids , Rats , Rats, Wistar , Serotyping , Transduction, Genetic
3.
Eur J Neurosci ; 28(8): 1467-79, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18973572

ABSTRACT

Even after reconstructive surgery, major functional impairments remain in the majority of patients with peripheral nerve injuries. The application of novel emerging therapeutic strategies, such as lentiviral (LV) vectors, may help to stimulate peripheral nerve regeneration at a molecular level. In the experiments described here, we examined the effect of LV vector-mediated overexpression of nerve growth factor (NGF) and glial cell line-derived neurotrophic factor (GDNF) on regeneration of the rat peripheral nerve in a transection/repair model in vivo. We showed that LV vectors can be used to locally elevate levels of NGF and GDNF in the injured rat peripheral nerve and this has profound and differential effects on regenerating sensory and motor neurons. For sensory neurons, increased levels of NGF and GDNF do not affect the number of regenerated neurons 1 cm distal to a lesion at 4 weeks post-lesion but do cause changes in the expression of markers for different populations of nociceptive neurons. These changes are accompanied by significant alterations in the recovery of nociceptive function. For motoneurons, overexpression of GDNF causes trapping of regenerating axons, impairing both long-distance axonal outgrowth and reinnervation of target muscles, whereas NGF has no effect on these parameters. These observations show the feasibility of combining surgical repair of the transected nerve with the application of viral vectors. Furthermore, they show a difference between the regenerative responses of motor and sensory neurons to locally increased levels of NGF and GDNF.


Subject(s)
Genetic Vectors/therapeutic use , Lentivirus/genetics , Nerve Growth Factors/genetics , Nerve Regeneration/genetics , Peripheral Nerve Injuries , Peripheral Nerves/metabolism , Animals , Axons/metabolism , Biomarkers/metabolism , Female , Glial Cell Line-Derived Neurotrophic Factor/genetics , Motor Neurons/metabolism , Nerve Growth Factor/genetics , Nerve Tissue Proteins/metabolism , Nociceptors/metabolism , Peripheral Nerves/cytology , Peripheral Nervous System Diseases/therapy , Rats , Rats, Wistar , Recovery of Function/genetics , Sensory Receptor Cells/metabolism , Treatment Outcome , Up-Regulation/genetics
4.
Mol Cell Neurosci ; 39(1): 105-17, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18585464

ABSTRACT

Traumatic avulsion of spinal nerve roots causes complete paralysis of the affected limb. Reimplantation of avulsed roots results in only limited functional recovery in humans, specifically of distal targets. Therefore, root avulsion causes serious and permanent disability. Here, we show in a rat model that lentiviral vector-mediated overexpression of glial cell line-derived neurotrophic factor (GDNF) in reimplanted nerve roots completely prevents motoneuron atrophy after ventral root avulsion and stimulates regeneration of axons into reimplanted roots. However, over the course of 16 weeks neuroma-like structures are formed in the reimplanted roots, and regenerating axons are trapped at sites with high levels of GDNF expression. A high local concentration of GDNF therefore impairs long distance regeneration. These observations show the feasibility of combining neurosurgical repair of avulsed roots with gene-therapeutic approaches. Our data also point to the importance of developing viral vectors that allow regulated expression of neurotrophic factors.


Subject(s)
Genetic Vectors , Glial Cell Line-Derived Neurotrophic Factor/metabolism , Lentivirus , Nerve Regeneration/physiology , Radiculopathy/surgery , Spinal Nerve Roots , Animals , Atrophy/prevention & control , Brain-Derived Neurotrophic Factor/genetics , Brain-Derived Neurotrophic Factor/metabolism , Cells, Cultured , Culture Media, Conditioned , Female , Ganglia, Spinal/cytology , Genetic Therapy , Genetic Vectors/genetics , Genetic Vectors/metabolism , Glial Cell Line-Derived Neurotrophic Factor/genetics , Humans , Lentivirus/genetics , Lentivirus/metabolism , Motor Neurons/metabolism , Motor Neurons/pathology , Radiculopathy/pathology , Rats , Rats, Wistar , Recovery of Function , Schwann Cells/cytology , Schwann Cells/metabolism , Spinal Cord/cytology , Spinal Cord/metabolism , Spinal Nerve Roots/physiology , Spinal Nerve Roots/surgery , Transgenes
5.
BMC Ophthalmol ; 5: 12, 2005 Jun 13.
Article in English | MEDLINE | ID: mdl-15953392

ABSTRACT

BACKGROUND: Combining characteristic morphological and functional information in one image increases pathophysiologic understanding as well as diagnostic accuracy in most clinical settings. En-face optical coherence tomography (OCT) provides a high resolution, transversal OCT image of the macular area combined with a confocal image of the same area (OCT C-scans). Creating an overlay image of a conventional angiographic image onto an OCT image, using the confocal part to facilitate transformation, combines structural and functional information of the retinal area of interest. This paper describes the construction of such overlay images and their aid in improving the interpretation of OCT C-scans. METHODS: In various patients, en-face OCT C-scans (made with a prototype OCT-Ophthalmoscope (OTI, Canada) in use at the Department of Ophthalmology (Academic Medical Centre, Amsterdam, The Netherlands)) and conventional fluorescein angiography (FA) were performed. ImagePro, with a custom made plug-in, was used to make an overlay-image. The confocal part of the OCT C-scan was used to spatially transform the FA image onto the OCT C-scan, using the vascular arcades as a reference. To facilitate visualization the transformed angiographic image and the OCT C-scan were combined in an RGB image. RESULTS: The confocal part of the OCT C-scan could easily be fused with angiographic images. Overlay showed a direct correspondence between retinal thickening and FA leakage in Birdshot retinochoroiditis, localized the subretinal neovascular membrane and correlated anatomic and vascular leakage features in myopia, and showed the extent of retinal and pigment epithelial detachment in retinal angiomatous proliferation as FA leakage was subject to blocked fluorescence. The overlay mode provided additional insight not readily available in either mode alone. CONCLUSION: Combining conventional angiographic images and en-face OCT C-scans assists in the interpretation of both imaging modalities. By combining the physiopathological information in the angiograms with the structural information in the OCT scan, zones of leakage can be correlated to structural changes in the retina or pigment epithelium. This strategy could be used in the evaluation and monitoring of patients with complex central macular pathology.


Subject(s)
Choroid Diseases/diagnosis , Fluorescein Angiography/methods , Retinal Diseases/diagnosis , Tomography, Optical Coherence/methods , Humans , Ophthalmoscopes
6.
Neurobiol Dis ; 15(2): 394-406, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15006710

ABSTRACT

Rubrospinal neurons (RSNs) undergo marked atrophy after cervical axotomy. This progressive atrophy may impair the regenerative capacity of RSNs in response to repair strategies that are targeted to promote rubrospinal tract regeneration. Here, we investigated whether we could achieve long-term rescue of RSNs from lesion-induced atrophy by adeno-associated viral (AAV) vector-mediated gene transfer of brain-derived neurotrophic factor (BDNF). We show for the first time that AAV vectors can be used for the persistent transduction of highly atrophic neurons in the red nucleus (RN) for up to 18 months after injury. Furthermore, BDNF gene transfer into the RN following spinal axotomy resulted in counteraction of atrophy in both the acute and chronic stage after injury. These novel findings demonstrate that a gene therapeutic approach can be used to reverse atrophy of lesioned CNS neurons for an extended period of time.


Subject(s)
Atrophy/therapy , Brain-Derived Neurotrophic Factor/genetics , Gene Transfer Techniques , Genetic Vectors/genetics , Nerve Regeneration/genetics , Spinal Cord Injuries/therapy , Acute Disease , Animals , Atrophy/metabolism , Atrophy/physiopathology , Axotomy , Brain-Derived Neurotrophic Factor/metabolism , Brain-Derived Neurotrophic Factor/therapeutic use , Chronic Disease , Dependovirus/genetics , Disease Models, Animal , Efferent Pathways/growth & development , Efferent Pathways/pathology , Efferent Pathways/physiopathology , Genetic Vectors/therapeutic use , Male , Nerve Regeneration/drug effects , Neurons/drug effects , Neurons/metabolism , Rats , Reaction Time/genetics , Receptor, trkB/metabolism , Red Nucleus/growth & development , Red Nucleus/pathology , Red Nucleus/physiopathology , Retrograde Degeneration/metabolism , Retrograde Degeneration/physiopathology , Retrograde Degeneration/therapy , Spinal Cord/growth & development , Spinal Cord/pathology , Spinal Cord/physiopathology , Spinal Cord Injuries/metabolism , Spinal Cord Injuries/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...